gliclazide mr 30 mg prolonged-release tablets
brillpharma (ireland) limited - gliclazide - prolonged-release tablet - 30 milligram(s) - sulfonamides, urea derivatives; gliclazide
gliclazide krka 90 mg tabl. modif.-rel.
krka d.d. novo mesto d.d. - gliclazide 90 mg - modified-release tablet - 90 mg - gliclazide 90 mg - gliclazide
gliclazide mylan 80 mg tabl.
viatris gx bv-srl - gliclazide 80 mg - tablet - 80 mg - gliclazide 80 mg - gliclazide
gliclazide retard mylan 30 mg tabl. modif.-rel.
viatris gx bv-srl - gliclazide 30 mg - modified-release tablet - 30 mg - gliclazide 30 mg - gliclazide
gliclazide sandoz 30 mg tabl. modif.-rel.
sandoz sa-nv - gliclazide 30 mg - modified-release tablet - 30 mg - gliclazide 30 mg - gliclazide
gliclazide sandoz 60 mg tabl. modif.-rel.
sandoz sa-nv - gliclazide 60 mg - modified-release tablet - 60 mg - gliclazide 60 mg - gliclazide
gliclazide lupin mr gliclazide 60 mg modified release tablet blister pack
lupin australia pty limited - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: povidone; calcium hydrogen phosphate dihydrate; hypromellose; magnesium stearate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
taro-gliclazide mr tablet (extended-release)
sun pharma canada inc - gliclazide - tablet (extended-release) - 60mg - gliclazide 60mg - sulfonylureas
taro-gliclazide mr tablet (extended-release)
sun pharma canada inc - gliclazide - tablet (extended-release) - 30mg - gliclazide 30mg - sulfonylureas
mylan-gliclazide tablet
mylan pharmaceuticals ulc - gliclazide - tablet - 80mg - gliclazide 80mg - sulfonylureas